HIGHLIGHTS
- who: Mireia Guerau-de-Arellano from the National Institute of Arthritis and (NIH), United States Medical University of South Carolina have published the article: Akt isoforms in the immune system, in the Journal: (JOURNAL)
- what: Much of the work on Akt in macrophages focuses on the in_vitro-generated extreme phenotypes M1 and M2. The priming also depends on the activity of Akt and represents a potential strategy that can be employed to enhance the effectiveness of NK cell killing in cancer immunotherapy. This study showed that hyperlipidemia selectively activates Akt2 in Tregs and that Akt2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.